The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Revival in domestic business should also help overall revenue growth.
Russia's central bank early on Tuesday raised interest rates to 17 per cent to counter the 50 per cent rouble fall in six months.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
As the death toll in the country from coronavirus jumped by a record 445 to 13,699, the Centre maintained that the number of infections per lakh population was among the lowest in the world. The new cases surged by over 10,000 for the 11th day in a row and rose by 14,821 to take the total to 4,25,282, according to health ministry data.
Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Low growth visibility and trouble with regulators have resulted in lack of interest from investors
Ajit Mishra, vice president, Research, Religare Broking, answers your queries:
The private companies announced projects worth Rs 11.33 lakh crore (Rs 11.33 trillion) during 2014-16.
Indian pharma firms under European drug regulator's scanner.
Fixed-dose combinations are medicines that come mixed in a certain proportion.
Experts say the stock market correction in recent times increases the risk-reward in favour of large-cap stocks.
Sun Pharmaceutical, which is growing its dermatology and ophthalmic specialty business in the US will spend $460 million on R&D.
6 locations in New Delhi and 2 in Mumbai were raided.
.jpg)
In a letter to health minister Harsh Vardhan, the Indian Pharmaceutical Alliance, an industry body representing leading pharma companies, including Sun Pharma, Lupin, Dr Reddy's Labs, Cadila Health and Glenmark, stressed the need for an out-of-court settlement with health activists fighting for the rights of clinical trial participants.
FIIs are looking at the long-term story and initiatives of Indian pharma companies to transform themselves into global entities.
Better-than-expected financial results in Q3 due to higher revenue growth and margins in key markets fuel the rally
Geopolitical concerns, earnings sees investors rush to safe haven plays post the Union Budget presentation in July.
Ajit Mishra, vice president, Research, Religare Broking, answers readers' queries on stocks they own or want to buy.
Index heavyweight RIL surged 3% to end above Rs 1,000 mark while IT majors were also the top gainers.
Companies asked to give data for three batches instead of one; move may lead to significant rise in development cost of generics
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' queries on stocks they own or want to buy.
'To win a medal at the Olympics you need 12 to 15 Virdhawals and Sejwals.' 'We lack a swimming culture.' 'Countries like the US, Australia, France and China are powerhouses, with access to the best facilities.'
Data also show that several other leading domestic pharma companies have recalled their products from the US
Ajit Mishra, Vice President, Research, Religare Broking, answers readers's queries on stocks they own or want to buy.
'Pay-for-delay' settlements between drug patent-holders and generics manufacturers to delay the launch of cheaper generic medicine are increasingly being scrutinised by antitrust regulators
Another year of strong performance by these export-oriented sectors likely as US economy revives and rupee is expected to be under pressure.
